The findings highlight the NS3‐induced circ_0001175/miR‐130a‐5p/MDM4/P53 pathway as a potential therapeutic target, offering promising directions for treatment strategies in HCV‐related HCC. This evidence concerns the gene TP53 and hepatocellular carcinoma.